article thumbnail

Abstract WP21: The novel target and mechanism of clinically used Edaravone dexborneol for ischemic stroke in China

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP21-AWP21, February 1, 2025. Background and PurposeIncreasing evidence has shown that lipid metabolism disorder and oxidative stress play crucial roles in pathogenesis of ischemic stroke, both of which are closely related to ferroptosis. Edaravone dexboneol (Eda.B)

Strokes 40
article thumbnail

Abstract TP229: Comparison of 30-Day Readmission Rates in Elective and Nonelective Carotid Endarterectomy and Carotid Artery Stenting: A Nationwide Cohort Study

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATP229-ATP229, February 1, 2025. Frequently, carotid artery stenosis is found during stroke workup and these patients undergo revascularization during the same nonelective admission.

Stents 40
article thumbnail

Abstract 4145926: The Importance of Dietary Salt in the Process of Atherosclerosis The Results of the International Survey

Circulation

Excess salt in the diet was indicated as a recognized risk factor in the case of hypertension 82.4%, atrial fibrillation 28.8%, obesity 36.4%, type 2 diabetes 20.4%, lipid disorders 18.5%, heart failure 59.1%, stroke 56.9%, and atherosclerosis 42.2%. to even 53%.

article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.

Obesity 111